All tenders
75N91025C00024
Novel Iontophoretic Drug Delivery Device for Oral Cancer Treatment
National Institutes of Health · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- 75N91025C00024
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- Novel Iontophoretic Drug Delivery Device for Oral Cancer Treatment
- Source
- USASpending (Federal)
- Source ID
- usa-75N91025C00024
Details
- Location
- United States
Summary
Small Business Innovation Research (SBIR) award to Continuity Biosciences for developing an advanced iontophoretic device designed to provide localized and more effective treatment for oral cancer patients.
Description
DIRECT TO PHASE II SBIR CONCEPT AWARD FOR NOVEL IONTOPHORETIC DRUG DELIVERY DEVICE FOR LOCAL AND EFFECTIVE TREATMENT OF ORAL CANCER Awarded to: CONTINUITY BIOSCIENCES, LLC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2025/09/05 12:00:00 AM UTC
- Closing date
- 2027/09/04 12:00:00 AM UTC
Estimated value
$3.0M USD
Classification
Normalized category
Other